M
Matthew E. Levison
Researcher at Drexel University
Publications - 103
Citations - 14152
Matthew E. Levison is an academic researcher from Drexel University. The author has contributed to research in topics: Endocarditis & Bacteremia. The author has an hindex of 40, co-authored 103 publications receiving 13501 citations. Previous affiliations of Matthew E. Levison include University of Alabama & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Prevention of Infective Endocarditis Guidelines From the American Heart Association: A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Walter R. Wilson,Kathryn A. Taubert,Michael H. Gewitz,Peter B. Lockhart,Larry M. Baddour,Matthew E. Levison,Ann F. Bolger,Christopher H. Cabell,Masato Takahashi,Robert S. Baltimore,Jane W. Newburger,Brian L. Strom,Lloyd Y. Tani,Michael A. Gerber,Robert O. Bonow,Thomas J. Pallasch,Stanford T. Shulman,Anne H. Rowley,Jane C. Burns,Patricia Ferrieri,Timothy J. Gardner,David Goff,David T. Durack +22 more
TL;DR: In this article, the authors updated the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis that were last published in 1997, and the purpose of this statement is to update the recommendations.
Journal ArticleDOI
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
Jane W. Newburger,Masato Takahashi,Michael A. Gerber,Michael H. Gewitz,Lloyd Y. Tani,Jane C. Burns,Stanford T. Shulman,Ann F. Bolger,Patricia Ferrieri,Robert S. Baltimore,Walter R. Wilson,Larry M. Baddour,Matthew E. Levison,Thomas J. Pallasch,Donald A. Falace,Kathryn A. Taubert +15 more
TL;DR: Recommendations for the initial evaluation, treatment in the acute phase, and long-term management of patients with Kawasaki disease are intended to assist physicians in understanding the range of acceptable approaches for caring for patients withawasaki disease.
Journal ArticleDOI
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.
Walter R. Wilson,Kathryn A. Taubert,Michael H. Gewitz,Peter B. Lockhart,Larry M. Baddour,Matthew E. Levison,Ann F. Bolger,Christopher H. Cabell,Masato Takahashi,Robert S. Baltimore,Jane W. Newburger,Brian L. Strom,Lloyd Y. Tani,Michael A. Gerber,Robert O. Bonow,Thomas J. Pallasch,Stanford T. Shulman,Anne H. Rowley,Jane C. Burns,Patricia Ferrieri,Timothy J. Gardner,David Goff,David T. Durack +22 more
TL;DR: The committee concluded that only an extremely small number of cases of IE might be prevented by antibiotic prophylaxis for dental procedures even if suchProphylactic therapy were 100 percent effective.
Journal ArticleDOI
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association
Jane W. Newburger,Masato Takahashi,Michael A. Gerber,Michael H. Gewitz,Lloyd Y. Tani,Jane C. Burns,Stanford T. Shulman,Ann F. Bolger,Patricia Ferrieri,Robert S. Baltimore,Walter R. Wilson,Larry M. Baddour,Matthew E. Levison,Thomas J. Pallasch,Donald A. Falace,Kathryn A. Taubert +15 more
TL;DR: A new algorithm is proposed to aid clinicians in deciding which children with fever for ≥5 days and ≤4 classic criteria should undergo electrocardiography, receive intravenous gamma globulin (IVIG) treatment, or both for Kawasaki disease.
Journal ArticleDOI
Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association
Adnan S. Dajani,Kathryn A. Taubert,Walter R. Wilson,Ann F. Bolger,Arnold S. Bayer,Patricia Ferrieri,Michael H. Gewitz,Stanford T. Shulman,Soraya Nouri,Jane W. Newburger,Cecilia Hutto,Thomas J. Pallasch,Tommy W. Gage,Matthew E. Levison,Georges Peter,Gregory Zuccaro +15 more
TL;DR: Major changes were instituted to more clearly define when prophylaxis is or is not recommended, improve practitioner and patient compliance, reduce cost and potential gastrointestinal adverse effects, and approach more uniform worldwide recommendations.